Back

Pleiotropic effects of canagliflozin and dapagliflozin in cadio-oncology: a novel strategy to balance antitumor efficacy and cardiotoxicity in HER2-positive breast cancer therapy

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Protection and safety in cardio‑oncology Cardiotoxicity of Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

5 More presentations in this session

Presentation thumbnail
Adverse cardiovascular events associated with kinase inhibitors and the prognostic value of imaging – a single-center retrospective cohort study in cancer patients
Mr J. Singh (US)
Abstract
Presentation thumbnail
Febuxostat exacerbates doxorubicin-induced cardiac remodelling in a murine model of cardiomyopathy
Doctor S. Jezsoviczky (Budapest, HU)
Abstract
Presentation thumbnail
Genetic susceptibility to early anthracycline cardiotoxicity: the role of CBR3 polymorphisms
Miss A. Rozhanskiy (Sao Paulo, BR)
Abstract
Presentation thumbnail
Dynamic circulating microRNA signatures associated with cancer therapy-related cardiotoxicity in breast cancer patients
Doctor E. Oikonomou (Athens, GR)
Abstract
Presentation thumbnail
Sacubitril/valsartan and prevention of chemotherapy-induced cardiac dysfunction: meta-analysis of randomized trials
Doctor C. Fischer Bacca (Rio do Sul, BR)
Abstract

Access the full session

Session thumbnail
Protection and safety in cardio‑oncology

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Dapagliflozin in primary prevention of cardiotoxicity induced by anthracycline-trastuzumab therapy through activation of pAMPK and inhibition of MyD88 and NLRP-3
20 June 2025
thumbnail
Congress Presentation
The prognostic value of sodium-glucose co-transporter-2 inhibitors therapy among patients with cancer and diabetes mellitus, treated with immune checkpoint inhibitors
21 May 2023
thumbnail
ESC Journals
Breast cancer and cardiovascular health
25 September 2024
thumbnail
Congress Presentation
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
29 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources